|
Market Cap (3-Jul) $356,619,552 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 17 November 2021, 7:30. The announcement is marked as price sensitive, and is 32 page(s) in length and 2.78MB in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.642% short sold according to ASIC data. It was ranked the 243rd most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Immutep Global Webcast Slides to Discuss Clinical Results | 17 November 2021, 7:30 |
| Change in substantial holding | 16 November 2021, 18:19 |
| Immutep announces publication of SITC 2021 posters | 15 November 2021, 8:37 |
| Chinese Patent Granted for Efti with PD-1 Pathway Inhibitors | 15 November 2021, 8:37 |
You must be logged in to post a reply.
